Introduction {#s1}
============

*Mycoplasma bovis* is a member of the *Mycoplasmataceae* family in the class of *Mollicutes*. It was first identified as a causative agent of bovine mastitis in 1961, and it was later recognized as an important pathogen of bovine respiratory disease in 1976 (Caswell and Archambault, [@B5]). Although it has been 56 years since *M. bovis* has been identified, there is limited understanding regarding its pathogenesis and virulence.

Compared with other bacteria, pathogenic *Mycoplasma* species have not been found to produce conventional toxins. Although ADP-ribosyl-transferase was preliminarily described as a possible toxin in a *Mycoplasma pneumoniae* strain that exhibits ADP-ribosyltransferase activity and elicits a distinct pattern of cytopathology in mammalian cells (Kannan and Baseman, [@B20]), it is difficult to distinguish pathogenic and non-pathogenic *Mollicutes* based on such virulence-related factors. Liproproteins and secretory proteins might contribute to bacterial virulence. Membrane lipoproteins, such as variable surface proteins (Vsps), enolase, and Vpmax, play significant roles in the adhesion of *M. bovis* to host cells (Burki et al., [@B4]). Subsequent invasion of host cells may be beneficial for *in vivo* survival and the dissemination of *M. bovis* to different sites in its hosts (Kleinschmidt et al., [@B25]). Regarding secretory proteins, only a few, including one *M. bovis* secretory protein, have been discovered (Zhang et al., [@B44]). Secondary metabolites such as hydrogen peroxide (H~2~O~2~) are considered to play a significant role in the pathogenesis of some *Mycoplasma* species, including *M. pneumoniae* (Hames et al., [@B16]) and *Mycoplasma mycoides* subsp. *mycoides* small colony (*MmmSC*) (Pilo et al., [@B32]). However, variations in H~2~O~2~ production might not correlate with *M. bovis* virulence (Schott et al., [@B37]). Instead, *M. bovis* might modulate the host immune response by suppressing interferon-γ and tumor necrosis factor-α production by invading immune cells to support its persistence and systemic dissemination (Mulongo et al., [@B29]). Genome sequences might provide more evidence that explains *Mycoplasma* pathogenesis at the genetic level. Currently, the genomes of 28 *M. bovis* strains, including the wild-type strain HB0801 and the three attenuated strains in the present study, have been sequenced and published (Li et al., [@B27]; Wise et al., [@B41]; Qi et al., [@B35]). Pathogenicity islands (PAIs) play a significant role in genome evolution and pathogenesis because many virulence-related factors are shared and acquired by PAIs. However, no PAIs and secretory systems have been detected in any *Mycoplasma* species (Guo and Wei, [@B14]). Using the virulence factors database (VFDB), some virulence genes were identified in the *M. bovis* genome (Parker et al., [@B31]), but their impact on *M. bovis* virulence remains to be investigated.

*M. bovis* was first isolated from the milk of a cow with mastitis in 1983 (Chen et al., [@B7]) and subsequently from lesioned lung tissue of a calf with pneumonia in 2008 in China (Qi et al., [@B35]). To develop candidate live vaccines against *M. bovis*, one strain, HB0801, which was isolated from lesioned lung tissue, was passaged continuously *in vitro*, and three strains that were passaged 115, 150, and 180 times, designated as *M. bovis* HB0801-P115, HB0801-P150, and HB0801-P180, respectively, were tested individually in cattle. The resulting clinical signs and pathological changes demonstrated that their virulence decreased with increasing numbers of passages (Zhang et al., [@B45]). Thus, a comparative genomics analysis of the virulent, wild-type strain HB0801 and these three attenuated strains might reveal some novel clues regarding the pathogenesis and virulence mechanisms of *M. bovis*.

Hence, in this study, we sequenced the complete genomes of these three attenuated strains and performed a comprehensive genomic analysis between the wild-type and the three attenuated strains. Based on the results, we hypothesize that a 14.2-kb deleted DNA fragment, single-nucleotide polymorphisms (SNPs), and indels probably affect the expression of some potential virulence-related proteins in the attenuated strains. In addition, the decreased capability to produce H~2~O~2~ in the attenuated strains was confirmed.

Materials and methods {#s2}
=====================

*Mycoplasma* strains and culture conditions
-------------------------------------------

*M. bovis* strain HB0801 (GenBank accession no. [NC_018077.1](NC_018077.1)) was isolated from the lung of infected beef cattle in Hubei Province, China, and its genome was fully sequenced by our laboratory (Qi et al., [@B35]). The *M. bovis* HB0801 attenuated strains HB0801-P115, HB0801-P150, and HB0801-P180, abbreviated as P115, P150, and P180, respectively, which exhibit progressively decreasing virulence, were used (Zhang et al., [@B45]). All the strains were propagated in pleuropneumonia-like organism (PPLO) medium supplemented with 10% horse serum (Thermo Fisher Scientific, Waltham, MA, USA) at 37°C for 48--72 h as described previously (Zhang et al., [@B45]).

Library construction, DNA sequencing, and assembly
--------------------------------------------------

The DNA of strains P115, P150, and P180 was extracted using bacterial genomic DNA extraction kits (Tiangen, Beijing, China). The 454 pyrosequencing method was used to determine the whole genome sequences of strains P115, P150, and P180. Three paired-end sequencing libraries with 8-kb inserts were constructed at the China Tianjin Biochip Corporation (Tianjin, China). For each sample, one-fourth of a PicoTiterPlate was run on a Roche/454 GS FLX sequencer (454 Life Sciences, Branford, CT, USA) using titanium chemistry according to the manufacturer\'s recommendations. Finally, 83,750,973 bases with 286,408 reads were obtained for strain P115, while 80,961,239 bases with 277,020 reads were obtained for strain P150, and 83,589,289 bases with 260,056 reads were obtained for strain P180, resulting in 85.7-fold (P115), 82.8-fold (P150), and 85.5-fold (P180) depths of sequencing. All the reads for each genome were assembled *de novo* by the GS *De Novo* Assembler (version 2.6). Approximately 95% of reads were assembled for each genome, resulting in 11 scaffolds with 52 non-redundant contigs for strain P115, three scaffolds with 49 non-redundant contigs for strain P150, and one scaffold with 53 non-redundant contigs for strain P180. All the scaffolds were ordered and oriented according to the genome architecture of strain HB0801 (Qi et al., [@B35]). The N50 contig lengths of the large contigs (\>1 kb) of each strain were 31,437 bp (P115), 31,456 bp (P150), and 31,042 bp (P180). The total numbers of base pairs of the non-redundant contigs were 916,922 bp (P115), 919,584 bp (P150), and 918,470 bp (P180), which agrees with the previously reported genome size of 991,702 bp for strain HB0801. To fill gaps within the scaffolds, polymerase chain reactions (PCRs) and capillary electrophoresis sequencing were performed with primers designed near the gaps. After gap filling, all the generated reads were respectively mapped to the corresponding full genome sequence using Burrows--Wheeler Aligner software (Li and Durbin, [@B26]). With the help of deep sequencing coverage, possible homopolymer errors resulting from the 454 sequencing method were rectified manually.

Genome annotation and analysis
------------------------------

Open reading frames of the three passaged genomes (P115, P150, and P180) were predicted initially using Glimmer 3.02 (<http://www.cbcb.umd.edu/software/glimmer/>) and then modified using the translated nucleotide Basic Local Alignment Search Tool (BLAST) algorithm (<http://blast.ncbi.nlm.nih.gov/>) and compared to the genome of the primary strain HB0801 (GenBank accession no. [CP002058](CP002058)). The functions of the coding sequences in the passaged strains were defined by referencing strain HB0801 (Qi et al., [@B35]). A comparative analysis between these four strains (P115, P150, P180, and HB0801) was conducted using MEGA 5.0 (Tamura et al., [@B40]) and Mauve 2.3.1 (Darling et al., [@B10]) genome alignment software. In addition, we detected differences in SNPs and indel sites among these strains.

Confirmation of the 14.2-kb deleted region by PCR
-------------------------------------------------

To confirm the presence of the 14.2-kb deleted region during continuous passage, a putative lipoprotein-encoding gene (Mbov_0732) present in the deleted region was selected for PCR with forward (5′--AGCGACCAAAATACTAGAC --3′) and reverse (5′--TCGTTGCCACTGTATTCA--3′) primers using the following program: 95°C 3 min, followed by 30 cycles of 95°C for 30 s, 55°C for 30 s, and 72°C 2 min, followed by 72°C for 15 min and 16°C for 5 min.

Confirmation of SNPs and indels
-------------------------------

SNPs and indels might affect the expression of essential genes. Sixty-seven pairs of primers specific to the flanking sequences of the SNPs and indel sites were designed (Table [S1](#SM1){ref-type="supplementary-material"}) and Sanger DNA sequencing was performed with an ABI 3730 sequencer by China Tianjin Biochip Corporation (Tianjin, China).

Bioinformatics analysis of predicted proteins
---------------------------------------------

Differentially expressed proteins predicted by genome comparisons of the virulent HB0801 strain to its attenuated P115, P150, and P180 derivatives were classified into two categories: (i) proteins deleted in P115, P150, or P180 (Table [1](#T1){ref-type="table"}) and (ii) proteins displaying non-sense SNPs and indels (Table [2](#T2){ref-type="table"}). Protein functions and related metabolic pathways were assigned according to the Uniprot database (<http://www.uniprot.org/>) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) database (<http://www.kegg.jp/kegg-bin/show_organism?menu_type=pathway_maps&org=mbi>), respectively. To determine whether proteins are secreted and contain a signal peptide, we used Pred-lipo (<http://bioinformatics.biol.uoa.gr/PRED-LIPO/input.jsp>), the SignalP 4.1 server for the prediction of classical secreted proteins (<http://www.cbs.dtu.dk/services/SignalP/>), and the SecretomeP 2.0 server for the prediction of non-classical secreted proteins (<http://www.cbs.dtu.dk/services/SecretomeP/>). Moreover, to assess whether the SNPs were present at active sites or domains of the proteins and to obtain the conserved domains in the secretory proteins, we used the National Center for Biotechnology Information (NCBI) conserved domain database (<http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi>). Paralogs of the genes and percentages of identity between paralogs were determined with the NCBI BLAST algorithm (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>). Protein--Protein interactions were obtained using the STRING database ([www.string-db.org](http://www.string-db.org)).

###### 

**The 14 genes present in the 14.2-kb deleted region of the three attenuated strains**.

  **Gene number**          **Start site**   **Stop site**   **Encoding proteins**
  ------------------------ ---------------- --------------- ---------------------------------------------------------
  [Mbov_0722](Mbov_0722)   854,329          854,446         Ascorbate-specific PTS system enzyme IIB component
  [Mbov_0723](Mbov_0723)   854,545          856,353         Ascorbate-specific PTS system enzyme IIA component
  [Mbov_0724](Mbov_0724)   856,405          857,466         Phosphotriesterase family protein
  [Mbov_0725](Mbov_0725)   857,812          858,669         Predicted hydrolases of the HAD superfamily
  [Mbov_0726](Mbov_0726)   858,857          859,093         Hypothetical protein
  [Mbov_0727](Mbov_0727)   859,172          860,956         DNA methyltransferase
  [Mbov_0728](Mbov_0728)   861,333          861,512         Amino-terminal fragment of hypothetical protein; pseudo
  [Mbov_0729](Mbov_0729)   861,695          862,609         Putative lipoprotein
  [Mbov_0730](Mbov_0730)   862,734          863,949         Lipoprotein containing a frameshift mutation; pseudo
  [Mbov_0732](Mbov_0732)   864,069          865,058         Putative lipoprotein
  [Mbov_0733](Mbov_0733)   865,436          865,627         Hypothetical protein
  [Mbov_0734](Mbov_0734)   865,790          866,689         Conserved hypothetical protein
  [Mbov_0735](Mbov_0735)   866,753          868,621         Type III RM system methylase; pseudo
  [Mbov_0856](Mbov_0856)   865220           865,383         Putative lipoprotein

###### 

**SNPs and indels in the three attenuated strains, compared with strain HB0801, after resequencing and PCR confirmation**.

  **Serial number**   **Gene number**          **P115**   **P150**    **P180**    **SNP site**   **Encoding protein**
  ------------------- ------------------------ ---------- ----------- ----------- -------------- -----------------------------------------------------------
  1                   [Mbov_0018](Mbov_0018)   C-A        C-A         C-A         S17,328        Simple sugar ABC transporter ATP-binding protein
  2                   [Mbov_0134](Mbov_0134)   C-A        C-A         C-A         S151,187       Spermidine/putrescine ABC transporter ATP-binding protein
  3                   [Mbov_0160](Mbov_0160)   C-T        C-T         C-T         S183,285       D-lactate dehydrogenase
  4                   [Mbov_0206](Mbov_0206)   C-T        C-T         C-T         S241,786       Ribose-phosphate pyrophosphokinase
  5                   [Mbov_0350](Mbov_0350)   C-A        C-A         C-A         S418,864       Putative lipoprotein
  6                   [Mbov_0482](Mbov_0482)   T-C        T-C         T-C         S562,835       Enolase
  7                   [Mbov_0482](Mbov_0482)   G-A        G-A         G-A         S562,695       Enolase
  8                   [Mbov_0518](Mbov_0518)   C-T        C-T         C-T         S609,729       Putative lipoprotein
  9                   [Mbov_0533](Mbov_0533)   C-T        C-T         C-T         S628,787       Cation transporting ATPase
  10                  [Mbov_0567](Mbov_0567)   C-A        C-A         C-A         S669,593       Phosphate acetyltransferase
  11                  [Mbov_0584](Mbov_0584)   C-A        C-A         C-A         S691,444       Putative transmembrane protein
  12                  [Mbov_0640](Mbov_0640)   C-A        C-A         C-A         S742,189       Large-conductance mechanosensitive ion channel
  13                  [Mbov_0714](Mbov_0714)   C-A        C-A         C-A         S848,007       Predicted integral membrane protein
  14                  [Mbov_0767](Mbov_0767)   G-C        G-C         G-C         S901,268       Conserved hypothetical protein
  15                  [Mbov_0155](Mbov_0155)   --         C-T         C-T         S175,797       Pyruvate kinase
  16                  [Mbov_0165](Mbov_0165)   --         C-T         C-T         S187,262       Hypothetical protein
  17                  [Mbov_0522](Mbov_0522)   --         C-T         C-T         S618,377       Phosphopentomutase
  18                  [Mbov_0579](Mbov_0579)   --         A-T         A-T         S684,890       Membrane lipoprotein P81
  19                  [Mbov_0641](Mbov_0641)   --         G-A         G-A         S743,651       Heat shock protein GrpE
  20                  [Mbov_0714](Mbov_0714)   --         C-A         C-A         S845,529       Predicted integral membrane protein
  21                  [Mbov_0797](Mbov_0797)   --         G-A         G-A         S929,799       VspHB0801-5
  22                  [Mbov_0832](Mbov_0832)   --         A-C         A-C         S964,804       Thioredoxin
  23                  [Mbov_0049](Mbov_0049)   --         G-A         --          S58,153        Putative lipoprotein
  24                  [Mbov_0111](Mbov_0111)   C-T        --          --          S120,789       Putative lipoprotein
  25                  [Mbov_0212](Mbov_0212)   C-T        --          --          S247,443       Transketolase
  26                  [Mbov_0248](Mbov_0248)   G-T        --          --          S284,709       Integrase
  27                  [Mbov_0299](Mbov_0299)   --         --          G-A         S350,175       NADH dehydrogenase
  28                  [Mbov_0328](Mbov_0328)   --         --          C-A         S388,007       Exopolyphosphatase-related protein
  29                  [Mbov_0393](Mbov_0393)   C-A        --          --          S457,329       Putative membrane lipoprotein (ICEB-1 encoded)
  30                  [Mbov_0403](Mbov_0403)   C-T        --          --          S472,982       Transcription elongation factor
  31                  [Mbov_0540](Mbov_0540)   --         --          G-A         S638,676       Putative transmembrane protein
  32                  [Mbov_0553](Mbov_0553)   --         --          C-A         S628,101       Cation transporting ATPase
  33                  [Mbov_0565](Mbov_0565)   --         --          C-T         S667,404       L-lactate dehydrogenase
  34                  [Mbov_0702](Mbov_0702)   --         --          G-A         S833,489       Transcriptional accessory protein
  35                  [Mbov_0738](Mbov_0738)   --         --          T-C         S871,124       Putative transmembrane protein
  36                  [Mbov_0742](Mbov_0742)   --         --          G-A         S876,089       Glycerol ABC transporter ATP binding component
  37                  [Mbov_0816](Mbov_0816)   --         --          G-A         S950,221       Hypothetical protein
  38                  [Mbov_0824](Mbov_0824)   --         T-C         --          S957,308       Peptide chain release factor
  1                   [Mbov_0338](Mbov_0338)   --         Del A       Del A       D399,903       Alcohol dehydrogenase
  2                   [Mbov_0340](Mbov_0340)   --         Del CTAGT   Del CTAGT   D402,407       Putative transmembrane protein
  3                   [Mbov_0347](Mbov_0347)   --         Del CT      Del CT      D414,907       Putative lipoprotein
  4                   [Mbov_0356](Mbov_0356)   Del C      --          Del C       D423,697       Pseudogene of cytosine-specific methyltransferase
  5                   [Mbov_0525](Mbov_0525)   --         Del G       Del G       D620,722       Putative membrane lipoprotein
  6                   [Mbov_0581](Mbov_0581)   --         --          Del A       D687,694       Multiple sugar ABC transporter ATP-binding protein
  7                   [Mbov_0656](Mbov_0656)   Del G      Del G       Del G       D768,061       Putative lipoprotein (variable)
  8                   [Mbov_0682](Mbov_0682)   --         Del CT      Del CT      D798,998       Putative lipoprotein

*S, SNP; Del, deletion. The data are categorized into four categories. 1, SNP present in all three passages; 2, SNP present in two passages; 3, SNP present in one passage; 4, deletions found in the genes*.

The involvement of these proteins in virulence was further confirmed based on the whole genome of *M. bovis* HB0801 using the VFDB (<http://www.mgc.ac.cn/VFs/>) (Chen et al., [@B6]). The amino acid sequences of all the proteins were obtained from the NCBI. Each protein was aligned individually against the VFDB full dataset by the BLAST algorithm. A matrix was created by VFDB output, including VFDB hits against each protein in *M. bovis*, a related BLAST score, and an E-value. The matrix was filtered based on a BLAST score ≥80.

H~2~O~2~ production assay for representative passaged strains and mutants
-------------------------------------------------------------------------

H~2~O~2~ production was measured as described previously in *Mycoplasma mycoides* subsp. *capri* (Allam et al., [@B1]). Briefly, eight transposon-disrupted mutants in the deleted region of the attenuated strains, including Mbov_0723, Mbov_0724, Mbov_0725, Mbov_0727, Mbov_0730, Mbov_0732, Mbov_0734, and Mbov_0735, as well as different passages of *M. bovis* HB0801, including P1, P25, P50, P75, P100, P115, P150, and P180, were grown to mid-logarithmic phase. The transposon-disrupted mutants were prepared using the wild-type HB0801 strain and a Tn4001 transposon. The transposon disrupted the abovementioned genes that are present in the deleted region mentioned in Table [1](#T1){ref-type="table"}. Moreover, the Mbov_0723, Mbov_0724, Mbov_0725, Mbov_0727, Mbov_0730, Mbov_0732, Mbov_0734, and Mbov_0735 genes were transposon-disrupted at positions 85,6071, 85,7345, 858,521, 860,287, 863,914, 864,069, 866,042, and 866,786, respectively, in the genome. To assess H~2~O~2~ production, bacteria were harvested by centrifugation at 15,400 g for 4 min at 4°C. The pellets were washed three times in incubation buffer (67.7 mM HEPES, pH 7.3; 140 mM NaCl, and 7 mM MgCl~2~). After the final wash, the *M. bovis* pellets were resuspended in incubation buffer to a density of 10^8^ cells/ml and incubated for 20 min at 37°C. After the incubation, 10 μl of glycerol (10 mM) was added, and the samples were kept at 37°C for 30 min. H~2~O~2~ production was determined using commercial H~2~O~2~ assay kits (Cayman Chemical, Ann Arbor, MI, USA). Standard curve determination and specificity quality controls were performed according to the instructional manual. The experiments were performed in three independent replicates.

Statistical analysis
--------------------

To determine the statistical significance among the differences in SNPs after comparing all the genes of *M. bovis*, as well as among different SNP and indel types, a *z*-test for proportions (*z* = *p*ˆ-*p*0/√*p*0(1 − *p*0)/*n*) was applied to generate a *p*-value. Moreover, to determine the statistical significance of the genes involved in different KEGG pathways, a KEGG enrichment analysis was performed using the KOBAS 2.0 web server, and Fisher\'s exact test was used to analyze the data (Xie et al., [@B42]). To analyze differences in H~2~O~2~ production among the different strains, two-way analysis of variance was performed using GraphPad Prism version 5.0 (GraphPad Software, San Diego, CA, USA). *p* \< 0.05 were considered to be significantly different and are marked with an asterisk in the figures, while *p* \< 0.01 were considered to very significantly different and are marked with two asterisks in the figures.

Nucleotide sequence accession numbers
-------------------------------------

The complete genome sequences of the three attenuated strains were deposited in the GenBank database with the accession numbers [CP007589](CP007589) for P115, [CP007590](CP007590) for P150, and [CP007591](CP007591) for P180.

Results and discussion {#s3}
======================

A 14.2-kb deleted fragment is present in the genomes of the three attenuated strains
------------------------------------------------------------------------------------

Because of a lack of genetic tools and limited research techniques, there is limited understanding of the pathogenesis and virulence-related factors of *M. bovis*. Hence, the whole genomes of strains P115, P150, and P180 were sequenced and assembled, and a comparative study was performed to identify significant virulence-related factors. The genome structures of the virulent *M. bovis* HB0801 strain and the three attenuated strains are shown in Figure [1A](#F1){ref-type="fig"}. An analysis of the three attenuated strains and the wild-type HB0801 strain revealed that all the genomes of strains P115, P150, and P180 lost a 14.2-kb fragment compared with strain HB0801 (Figure [1B](#F1){ref-type="fig"} and Table [1](#T1){ref-type="table"}). Further analysis of the deleted fragment showed that it consists of 14 putative genes encoding ascorbate-specific phosphotransferase system (PTS) system enzyme IIB and IIA components, a phosphotriesterase family protein, predicted hydrolases of the haloacid dehalogenase (HAD) superfamily, DNA methyltransferase, and a type III restriction-modification (RM) system methylase, as shown in Table [1](#T1){ref-type="table"}. In addition, 38 strains that were passage between one and 115 times were shown by PCR to have a deletion in the Mbov_0732 gene. The results demonstrated that the 14.2-kb deletion occurred in passage 115 and onward as shown in Figure [S1](#SM1){ref-type="supplementary-material"}, indicating that the deletion was stably maintained in the passaged strains after its occurrence.

![**Genomic comparison of ***M. bovis*** strains HB0801 (P1), P115, P150, and P180. (A)** Genome structures of the *M. bovis* HB0801 strain and the three attenuated strains; **(B)** Serial propagation of HB0801 resulted in the deletion of a 14.2-kb fragment in the genome of the three attenuated strains. The red lines show the lengths of the genomes of respective strains. The lengths of the P115, P150, and P180 strains are reduced and shown in dashes at the ends of the lines.](fcimb-07-00177-g0001){#F1}

SNPs and indels
---------------

In addition to the 14.2-kb deleted region, a genome comparison between strain HB0801 and the attenuated strains revealed many SNPs and indels. Sixty-seven non-sense SNP sites were tested with PCR and DNA sequencing, and 38 SNPs were confirmed (Table [2](#T2){ref-type="table"}). In agreement with the increasing attenuation tendency resulting from continuous passage, strains that were subjected to more passages had more SNPs, and the SNPs in the strains that were subjected to fewer passages were shared by the higher passaged strains. The numbers of SNPs were 31, 24, and 19 for the P180, P150, and P115 strains, respectively. In addition, eight nucleotide deletions were found, and their frequencies of occurrence followed a pattern that was similar to that of the SNPs (Table [2](#T2){ref-type="table"}). These changes in the genomes were analyzed statistically with a *z*-test of proportions, and the results showed that there were significant differences in the numbers of SNPs, indels, and SNPs+indels between the wild-type strain and each of the attenuated strains, and between any two attenuated strains (normalized *p* \< 0.00001).

Detection of paralogs in the *M. bovis* genome
----------------------------------------------

Theoretically, the functions of some genes containing SNPs or deletions could be compensated by their paralogs in the genome. Hence, the FASTA sequences of such paralogs were aligned with a reference protein by the BLAST algorithm to determine the percentage of identity between them (Table [S2](#SM1){ref-type="supplementary-material"}); a reference protein is a protein that is found in our genomics data (Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}). The results showed that the proteins that have paralogs in our genomics data included four of the 14 genes in the 14.2-kb deleted region (Mbov_0727, Mbov_0729, Mbov_0732, and Mbov_0856) and 14 of the 46 genes containing SNPs or indels (Mbov_0018, Mbov_0049, Mbov_0111, Mbov_0134, Mbov_0338, Mbov_0347, Mbov_0350, Mbov_0393, Mbov_0518, Mbov_0525, Mbov_0581, Mbov_0682, Mbov_0742, and Mbov_0832). Hence, the genes responsible for virulence attenuation would likely include the other 10 genes in the 14.2-kb deleted region and the 32 genes with SNPs and indels, but which lacked paralogs.

Prediction of protein--protein interactions
-------------------------------------------

The proteins listed in Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"} were input into the STRING database to predict potential protein-protein interactions using the type strain *M. bovis* PG45 as the database default reference. Protein--protein interaction maps are given for 13 of the 60 input proteins (Figure [2](#F2){ref-type="fig"}). Different colored lines show different types of interactions. Hence, more lines show more interactions and an increased probability of a protein-protein interaction. The interactions among the proteins are highlighted in evidence view (Figure [2A](#F2){ref-type="fig"}). In evidence view, all possible interactions are shown. Different colored lines show different types of interactions e.g., gene fusion, co-occurrence, co-expression, experiments, databases, text mining etc. While in interactive view, the interactive proteins are clustered together based on interaction and co-occurrence. The evidence (Figure [2A](#F2){ref-type="fig"}) and interactive views (Figure [2B](#F2){ref-type="fig"}) showed that the most significant proteins that are likely to interact include enolase (Mbov_0482), pyruvate kinase (Mbov_0155), transketolase (Mbov_0212), L-lactate dehydrogenases (Mbov_0565), and D-lactate dehydrogenases (Mbov_0160), suggesting that these proteins might function together, and thus, that they are the strongest candidates for explaining the attenuated virulence of highly passage *M. bovis* strains.

![**Protein--protein interaction map of the available proteins from the list of analyzed proteins from Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}**. Different colored lines show different types of interactions. Hence, more lines show more interactions and an increased probability of a protein--protein interaction. The image and related details were retrieved from the STRING database (<http://www.string-db.org/>). **(A)** Evidence view; **(B)** Interactive view. In evidence view, all possible interactions are shown. Different colored lines show different types of interactions e.g., gene fusion, co-occurrence, co-expression, experiments, databases, text mining etc. While in interactive view, the interactive proteins are clustered together based on interaction and co-occurrence.](fcimb-07-00177-g0002){#F2}

Pathway enrichment assay
------------------------

A KEGG enrichment analysis was performed to determine whether the mutated genes in Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"} are enriched in some important metabolic pathways. Fifteen genes were shown to be enriched in 15 metabolic pathways. Furthermore, 10 of the 15 genes were involved in more than one pathway (Figure [3](#F3){ref-type="fig"} and Table [S3](#SM1){ref-type="supplementary-material"}). The 10 genes and the involved numbers of pathways numbers are Mbov_0155 and Mbov_0482 (seven), Mbov_0206 and Mbov_0565 (six), Mbov_0212 (five), Mbov_0567 (four), Mbov_0338 (three), and Mbov_0522, Mbov_0722, and Mbov_0723 (two). Among them, Mbov_0155, Mbov_0212, Mbov_0482, and Mbov_0565 were also identified in the protein-protein interaction analysis. Theoretically, proteins involved in more pathways should be more likely to play a significant role in *M. bovis* virulence. However, among the pathways, biosynthesis of secondary metabolites, biosynthesis of antibiotics, carbon metabolism, pyruvate metabolism, biosynthesis of amino acids, glycolysis/gluconeogenesis, pentose phosphate pathway, purine metabolism, and ATP-binding cassette (ABC) transporters were enriched in more pathways (six, six, five, four, four, four, three, three, and three, respectively).

![**The mutated genes from Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"} that are enriched in some metabolic pathways**. Fifteen genes were shown to be enriched in 15 metabolic pathways. Ten of the fifteen genes are involved in more than one pathway.](fcimb-07-00177-g0003){#F3}

Conserved domain analysis
-------------------------

Twelve predicted secretory proteins with signal peptides, which includes those encoded by 10 genes (Mbov_0049, Mbov_0111, Mbov_0347, Mbov_0350, Mbov_0393, Mbov_0518, Mbov_0525, Mbov_0579, Mbov_0682, and Mbov_0797) that have SNPs (Table [2](#T2){ref-type="table"}) and the Mbov_0729 and Mbov_0856 genes, which are deleted, were identified (Table [1](#T1){ref-type="table"}). A conserved domain analysis (**Table 4**) identified the presence of conserved domains in the eight secretory proteins mentioned in Table [3](#T3){ref-type="table"}, but not in Mbov_0111, Mbov_0393, Mbov_0525, and Mbov_0856. Liproproteins and secretory proteins might contribute to bacterial virulence and pathogenesis because they are involved in many phenomena, ranging from cellular physiology through immune responses to virulence. Some secretory proteins were discovered previously in *M. bovis* (Khan et al., [@B22]; Zhang et al., [@B44]). Many other genes in the *M. bovis* genome are predicted to encode putative lipoproteins and secretory proteins, but whether these proteins exist in a functional form and how they are related to virulence need to be determined. The most significant conserved domains with available functions include CDC45 (Mbov_0797), DUF1388 (Mbov_0797), structural maintenance of chromosomes (SMC) (Mbov_0049), Rad23 (Mbov_0682), and peptidase C19 (Mbov_0729) (Table [4](#T4){ref-type="table"}). CDC45 is required for the initiation of DNA replication (Saha et al., [@B36]). Members of the DUF1388 family function as the main targets for neurofilament-directed protein kinases *in vivo*. SMC proteins are essential for successful chromosome transmission during replication, and segregation of the genome, including chromosome condensation, recombination, DNA repair, and epigenetic silencing of gene expression (Haering et al., [@B15]). Rad23 family proteins are used for targeting nucleotide excision repair to specific parts of the genome. Peptidase C19 is a deubiquitinating enzyme that can deconjugate ubiquitin or ubiquitin-like proteins from ubiquitin-conjugated proteins (De Jong et al., [@B11]). The functions of the other domains are currently unknown.

###### 

**Putative secretory proteins with signal peptides**.

  **Gene**                 **Name**                                         **D**   **Smean**   **Cmax**   **Pos**
  ------------------------ ------------------------------------------------ ------- ----------- ---------- ---------
  [Mbov_0049](Mbov_0049)   Putative lipoprotein                             0.638   0.724       0.556      33
  [Mbov_0111](Mbov_0111)   Putative lipoprotein                             0.498   0.716       0.181      26
  [Mbov_0347](Mbov_0347)   Putative lipoprotein                             0.623   0.798       0.363      32
  [Mbov_0350](Mbov_0350)   Putative lipoprotein                             0.566   0.845       0.184      32
  [Mbov_0393](Mbov_0393)   Putative membrane lipoprotein (ICEB-1 encoded)   0.465   0.68        0.185      24
  [Mbov_0518](Mbov_0518)   Putative lipoprotein                             0.551   0.88        0.176      32
  [Mbov_0525](Mbov_0525)   Putative membrane lipoprotein                    0.693   0.893       0.344      23
  [Mbov_0579](Mbov_0579)   Membrane lipoprotein P81                         0.591   0.884       0.184      25
  [Mbov_0682](Mbov_0682)   Putative lipoprotein                             0.722   0.853       0.533      32
  [Mbov_0729](Mbov_0729)   Putative lipoprotein                             0.568   0.792       0.206      25
  [Mbov_0797](Mbov_0797)   VspHB0801-5                                      0.659   0.946       0.238      23
  [Mbov_0856](Mbov_0856)   Putative lipoprotein                             0.641   0.918       0.229      25

*Secretory proteins with signal peptides were identified by Pred-lipo (<http://bioinformatics.biol.uoa.gr/PRED-LIPO/input.jsp>), the SignalP 4.1 server for the prediction of classically secreted proteins (<http://www.cbs.dtu.dk/services/SignalP/>), and the SecretomeP 2.0 server for the prediction of non-classically secreted proteins (<http://www.cbs.dtu.dk/services/SecretomeP/>) using a default cutoff value of 0.45. Cmax is the signal peptide cleavage site score. Smean is the average score of the putative signal peptide. D is the discrimination score that differentiates signal peptides from non-signal peptides. Pos is the cleavage position of the protein*.

###### 

**Conserved domains in the secretory proteins**.

  **Gene**                 **Name**                   **Domain**                           **Name**
  ------------------------ -------------------------- ------------------------------------ ----------------------------------
  [Mbov_0049](Mbov_0049)   Putative lipoprotein       330--636                             SMC_prok_A
  [Mbov_0347](Mbov_0347)   Putative lipoprotein       29--176                              PLN02967
  [Mbov_0350](Mbov_0350)   Putative lipoprotein       304--660                             DUF31
  [Mbov_0518](Mbov_0518)   Putative lipoprotein       392--764                             DUF31
  [Mbov_0579](Mbov_0579)   Membrane lipoprotein P81   257--482 & 570--698                  Lipoprotein_X & Lipoprotein_10
  [Mbov_0682](Mbov_0682)   Putative lipoprotein       6--175, 183--253                     PRK08581, rad23
  [Mbov_0729](Mbov_0729)   Putative lipoprotein       189--286                             Peptidase C19
  [Mbov_0797](Mbov_0797)   VspHB0801-5                46--74, 70--98, 195--253, 152--180   DUF1388, DUF1388, CDC45, DUF1388

*The analysis highlights the presence of conserved domains in the secretory proteins. The analysis was performed using the NCBI server ([http://www.ncbi.nlm.nih.gov/Structure/](http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi)[cdd/wrpsb.cgi](http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi))*.

The virulence-related factors identified by the VFDB
----------------------------------------------------

To further investigate the virulence-related factors that contribute to the attenuation of highly passaged *M. bovis* strains, all the proteins of *M. bovis* were analyzed using the VFDB. In the VFDB full dataset, all proteins related to known and predicted virulence-related factors are present. Seventy-two genes in the *M. bovis* genome were shown to encode virulence-related factors based on a BLAST score ≥80 (Table [5](#T5){ref-type="table"}). Although no virulence-related factor-encoding genes were found in the 14.2-kb deleted region, eight genes overlapped with those containing SNPs and indels (Table [2](#T2){ref-type="table"}). In decreasing order of BLAST scores, they are Mbov_0482, Mbov_0533, Mbov_0581, Mbov_0338, Mbov_0134, Mbov_0742, Mbov_0018, and Mbov_0797.

###### 

**Virulence-related factor identification in ***M. bovis*** using the VFDB**.

  **Gene id**              **VFDB hit**                                                                                                                        **Score**   **E-value**
  ------------------------ ----------------------------------------------------------------------------------------------------------------------------------- ----------- -------------
  [Mbov_0560](Mbov_0560)   IS1634AV transposase \[*MmmSC*\]                                                                                                    1,060       0
  [Mbov_0481](Mbov_0481)   elongation factor Tu \[*Mycoplasma agalactiae*\]                                                                                    754         0
  [Mbov_0016](Mbov_0016)   predicted lipoprotein \[monocytic differentiation factor\] \[*M. agalactiae*\]                                                      743         0
  [Mbov_0842](Mbov_0842)   hypothetical protein \[Mg^2+^ transport\] \[*Salmonella enterica* subsp. *arizonae*\]                                               657         0
  [Mbov_0174](Mbov_0174)   P48, predicted lipoprotein \[*M. agalactiae*\]                                                                                      627         1.00E-180
  [Mbov_0103](Mbov_0103)   pyruvate dehydrogenase E1 component \[*M. agalactiae*\]                                                                             611         1.00E-175
  [Mbov_0703](Mbov_0703)   endopeptidase Clp ATP-binding chain C \[*Listeria monocytogenes*\]                                                                  546         1.00E-155
  [Mbov_0157](Mbov_0157)   molecular chaperone DnaK \[*Chlamydia trachomatis*\]                                                                                475         1.00E-134
  [Mbov_0482](Mbov_0482)   phosphopyruvate hydratase \[*Streptococcus agalactiae*\]                                                                            443         1.00E-124
  [Mbov_0033](Mbov_0033)   oligopeptide ABC transporter \[*M. mycoides* subsp. *mycoides*\]                                                                    414         1.00E-116
  [Mbov_0062](Mbov_0062)   glyceraldehyde 3-phosphate dehydrogenase \[*Streptococcus sanguinis*\]                                                              404         1.00E-113
  [Mbov_0310](Mbov_0310)   SecA DEAD domain protein \[*Mycobacterium vanbaalenii*\]                                                                            392         1.00E-109
  [Mbov_0520](Mbov_0520)   NAD dependent DNA ligase \[*Leptospira interrogans* serovar Lai\]                                                                   332         3.00E-91
  [Mbov_0428](Mbov_0428)   PgPepO oligopeptidase \[*Mycobacterium* sp. JLS\]                                                                                   280         3.00E-75
  [Mbov_0488](Mbov_0488)   peptide methionine sulfoxide reductase \[*Neisseria meningitidis*\]                                                                 280         8.00E-76
  [Mbov_0687](Mbov_0687)   lipid A ABC exporter \[*Haemophilus somnus*\]                                                                                       273         2.00E-73
  [Mbov_0302](Mbov_0302)   RNA polymerase, RpoD family \[*Mycobacterium gilvum*\]                                                                              236         3.00E-62
  [Mbov_0491](Mbov_0491)   lipid A export ATP-binding protein MsbA \[*Haemophilus influenzae* PittGG\]                                                         234         1.00E-61
  [Mbov_0068](Mbov_0068)   lipoyltransferase and lipoate-protein ligase family protein \[*L. monocytogenes*\]                                                  231         3.00E-61
  [Mbov_0010](Mbov_0010)   putative lipase protein ligase A \[*Listeria ivanovii* subsp. *ivanovii*\]                                                          226         1.00E-59
  [Mbov_0009](Mbov_0009)   hypothetical protein \[*Listeria innocua*\]                                                                                         225         4.00E-59
  [Mbov_0533](Mbov_0533)   magnesium-translocating P-type ATPase \[*S. enterica* subsp. *enterica*\]                                                           222         7.00E-58
  [Mbov_0280](Mbov_0280)   predicted lipoprotein \[*M. agalactiae*\]                                                                                           207         6.00E-54
  [Mbov_0693](Mbov_0693)   P65 lipoprotein-like protein \[*Mycoplasma mobile* 163K\]                                                                           201         7.00E-51
  [Mbov_0539](Mbov_0539)   probable phosphomannomutase \[*Haemophilus ducreyi*\]                                                                               199         5.00E-51
  [Mbov_0532](Mbov_0532)   glucose-1-phosphate uridylyltransferase \[*Bacillus thuringiensis*\]                                                                197         5.00E-51
  [Mbov_0490](Mbov_0490)   lipid transporter ATP-binding/permease \[*H. influenzae*\]                                                                          187         2.00E-47
  [Mbov_0675](Mbov_0675)   adenosine synthase A \[*Streptococcus pyogenes*\]                                                                                   177         1.00E-44
  [Mbov_0674](Mbov_0674)   membrane nuclease \[*Mycoplasma pulmonis*\]                                                                                         173         2.00E-43
  [Mbov_0796](Mbov_0796)   variable surface lipoprotein W \[*M. agalactiae* PG2\]                                                                              168         3.00E-42
  [Mbov_0438](Mbov_0438)   type III secretion system ATPase \[*Aeromonas salmonicida* subsp. *salmonicida*\]                                                   160         2.00E-39
  [Mbov_0798](Mbov_0798)   variable surface lipoprotein V \[*M. agalactiae* PG2\]                                                                              160         8.00E-40
  [Mbov_0688](Mbov_0688)   fused lipid transporter subunits of ABC superfamily \[*H. influenzae*\]                                                             159         4.00E-39
  [Mbov_0581](Mbov_0581)   ABC transporter ATP-binding protein \[*Mycobacterium leprae*\]                                                                      157         2.00E-38
  [Mbov_0341](Mbov_0341)   P65 lipoprotein-like protein \[*M. mobile*\]                                                                                        154         9.00E-37
  [Mbov_0440](Mbov_0440)   type III secretion system ATPase \[*Desulfovibrio vulgaris*\]                                                                       153         3.00E-37
  [Mbov_0745](Mbov_0745)   (CbuG_0446) hypothetical protein \[type IV secretion system effector\] \[*Coxiella burnetii* CbuG_Q212\]                            153         8.00E-38
  [Mbov_0115](Mbov_0115)   oligopeptide ABC transporter \[*MmmSC*\]                                                                                            150         4.00E-36
  [Mbov_0338](Mbov_0338)   alcohol dehydrogenase \[MymA operon\] \[*Mycobacterium* sp. JLS\]                                                                   140         2.00E-33
  [Mbov_0353](Mbov_0353)   zinc-type alcohol dehydrogenase \[*Mycobacterium ulcerans*\]                                                                        134         1.00E-31
  [Mbov_0508](Mbov_0508)   flagellum-specific ATP synthase FliI \[*Legionella pneumophila* subsp. *pneumophila*\]                                              131         1.00E-30
  [Mbov_0038](Mbov_0038)   predicted cytoskeletal protein \[*Mycoplasma penetrans*\]                                                                           124         1.00E-27
  [Mbov_0134](Mbov_0134)   maltodextrin import ATP-binding protein \[*Mycobacterium abscessus* subsp. *bolletii*\]                                             122         4.00E-28
  [Mbov_0168](Mbov_0168)   trigger factor \[*Streptococcus mutans*\]                                                                                           120         2.00E-27
  [Mbov_0595](Mbov_0595)   hemolysin secretion protein HlyB \[*Escherichia coli*\]                                                                             120         8.00E-28
  [Mbov_0742](Mbov_0742)   sugar ABC transporter ATP-binding protein \[*M. gilvum* Spyr1\]                                                                     117         1.00E-26
  [Mbov_0034](Mbov_0034)   oligopeptide ABC transporter \[*M. mycoides* subsp. *mycoides*\]                                                                    113         3.00E-25
  [Mbov_0535](Mbov_0535)   phthiocerol dimycocerosate and phenolic glycolipid biosynthesis and transport \[*Mycobacterium avium* subsp. *paratuberculosis*\]   110         9.00E-25
  [Mbov_0509](Mbov_0509)   HrcN \[type III secretion system\] \[*Pantoea stewartii* subsp. *stewartii* str. SS104\]                                            106         4.00E-23
  [Mbov_0843](Mbov_0843)   HitC iron(III) ABC transporter ATP-binding protein \[*H. influenzae*\]                                                              104         1.00E-22
  [Mbov_0099](Mbov_0099)   lipoprotein diacylglyceryl transferase \[*L. innocua*\]                                                                             103         1.00E-22
  [Mbov_0233](Mbov_0233)   serine/threonine protein kinase \[*Mycobacterium tuberculosis*\]                                                                    102         1.00E-27
  [Mbov_0291](Mbov_0291)   fibronectin-binding protein \[*Tannerella forsythia*\]                                                                              100         5.00E-21
  [Mbov_0810](Mbov_0810)   segregation and condensation protein B \[*S. agalactiae*\]                                                                          100         5.00E-22
  [Mbov_0029](Mbov_0029)   ABC transporter, ATP-binding protein \[*H. somnus*\]                                                                                99          3E-21
  [Mbov_0594](Mbov_0594)   iron ABC transporter ATP-binding protein \[*Corynebacterium pseudotuberculosis*\]                                                   96          3.00E-20
  [Mbov_0018](Mbov_0018)   iron-uptake permeate ATP-binding protein \[*Neisseria lactamica*\]                                                                  93          4.00E-19
  [Mbov_0152](Mbov_0152)   lipopolysaccharide core biosynthesis protein \[*Helicobacter pylori*\]                                                              92          8.00E-20
  [Mbov_0114](Mbov_0114)   oligopeptide ABC transporter \[*MmmSC*\]                                                                                            89          6.00E-18
  [Mbov_0121](Mbov_0121)   ABC-type transporter \[*Enterococcus faecalis*\]                                                                                    89          9.00E-18
  [Mbov_0375](Mbov_0375)   Putative short-chain type dehydrogenase/reductase \[*Mycobacterium canettii*\]                                                      89          3.00E-18
  [Mbov_0554](Mbov_0554)   LicA protein \[LOS\] \[*H. somnus* 129PT\]                                                                                          89          3.00E-18
  [Mbov_0312](Mbov_0312)   AdhD alcohol dehydrogenase \[*Mycobacterium intracellulare* MOTT-02\]                                                               88          7.00E-18
  [Mbov_0279](Mbov_0279)   HlyC/CorC family \[hemolysin\] \[*Clostridium botulinum* A str. ATCC 19397\]                                                        87          3.00E-17
  [Mbov_0232](Mbov_0232)   protein phosphatase PrpC \[*L. monocytogenes*\]                                                                                     86          2.00E-17
  [Mbov_0064](Mbov_0064)   beta-1,3 galactosyltransferase \[*Campylobacter jejuni* subsp. *jejuni*\]                                                           85          6.00E-17
  [Mbov_0784](Mbov_0784)   elongation factor Tu \[EF-Tu\] \[*M. pulmonis* UAB CTIP\]                                                                           84          3.00E-16
  [Mbov_0427](Mbov_0427)   Dot/Icm type IV secretion system effector \[*L. pneumophila*\]                                                                      83          1.00E-16
  [Mbov_0797](Mbov_0797)   variable surface lipoprotein W (VpmaW precursor) \[*M. agalactiae*\]                                                                82          6.00E-16
  [Mbov_0156](Mbov_0156)   variable surface lipoprotein Y \[*M. agalactiae*\]                                                                                  80          2.00E-15
  [Mbov_0307](Mbov_0307)   iron-dicitrate transporter ATP-binding subunit \[*Vibrio parahaemolyticus*\]                                                        80          1.00E-15
  [Mbov_0845](Mbov_0845)   ATPase \[Proteasome-associated proteins\] \[*Mycobacterium marinum*\]                                                               80          4.00E-15

*Virulence proteins found in the VDFB for M. bovis HB0801 proteins using BLAST are listed as a VFDB hit. Scores and E-values were generated by the BLAST algorithm. The data were filtered by BLAST scores ≥ 80*.

Analysis of critical deleted genes and genes with SNPs and indels
-----------------------------------------------------------------

By combining the above results for the deleted genes and the genes with SNPs and indels, 11 critical genes that likely contribute to the attenuation of highly passaged *M. bovis* strains were identified, and they include (in order of decreasing importance) Mbov_0722, Mbov_0723, Mbov_0482, Mbov_0565, Mbov_0155, Mbov_0581, Mbov_0742, Mbov_0299, Mbov_0212, Mbov_0797, and Mbov_0567.

Among the deleted genes, Mbov_0722 and Mbov_0723 are highlighted. They encode ascorbate-specific PTS enzyme IIB and IIA components, respectively, which function in ascorbate and aldarate metabolism pathways by involving the PTS, the major carbohydrate transport system in bacteria, and they are responsible for the conversion of L-ascorbate into L-ascorbate-6 phosphate, as shown in Figure [S2](#SM1){ref-type="supplementary-material"} (Postma et al., [@B34]). The final product of this pathway is D-xylulose-5 phosphate, which is an intermediate in the pentose phosphate pathway. As is known, the primary purpose of this pathway is to generate a reducing equivalent of NADPH that can be used in reductive biosynthesis reactions, while the production of the pentose phosphate pathway intermediates ribose 5-phosphate and erythrose 4-phosphate are used to synthesize nucleotides and nucleic acids, and aromatic amino acids, respectively. In addition, this sugar has a role in gene expression, mainly by promoting the ChREBP transcription factor in the well-fed state (Iizuka and Horikawa, [@B18]). Hence, because of the deficiencies of both proteins in the attenuated strains, these related metabolic functions would be less efficient. Because the occurrence of the 14.2-kb deleted region began at passage 115 and was maintained from passages 115 through 180, these metabolic defects might contribute to the increasing attenuation of highly passaged *M. bovis* strains.

The enolase encoded by Mbov_0482 is considered to be a virulence-related factor, and it participates in seven metabolic pathways and interacts with other proteins as described previously. It catalyzes the reversible conversion of 2-phosphoglycerate into phosphoenolpyruvate. This reaction is present in the glycolysis/gluconeogenesis pathways of *M. bovis*, as shown in Figure [S3](#SM1){ref-type="supplementary-material"}. Prokaryotic α-enolase may contribute to pathophysiological processes (Pancholi, [@B30]). A surface-associated enolase is an adhesion-related factor of *M. bovis* that contributes to adherence by binding plasminogen (Song et al., [@B39]). The immunogenicity of enolase has also been observed in *Mycoplasma synoviae* (Bercic et al., [@B2]) and *Mycoplasma capricolum* subsp. *capripneumoniae* (Zhao et al., [@B46]). Hence, enolase might be a significant protein that contributes to the virulence of *M. bovis*. However, two SNPs were not detected inside the enolase-encoding gene, but were located approximately 300 bp upstream of the gene, suggesting that both SNPs might cause some change in the promoter region.

Like enolase, L-lactate dehydrogenase encoded by Mbov_0565 is another protein that is important for metabolism and as a virulence-related factor. It interconverts L-lactate to pyruvate. Additionally, this enzyme works in many metabolic pathways, including glycolysis/gluconeogenesis, cysteine and methionine metabolism, pyruvate metabolism, and propanoate metabolism. Hence, this lactate dehydrogenase plays significant roles in a variety of metabolic processes. Moreover, L-lactate dehydrogenase was shown to be surface expressed and to interact with plasminogen (Grundel et al., [@B12]). Furthermore, because of the SNP in the L-lactate dehydrogenase-encoding gene, a polar amino acid (threonine) was converted to a non-polar amino acid (methionine).

Pyruvate kinase (Mbov_0155) is also a very active protein in metabolism and energy production. It catalyzes the conversion of phosphoenolpyruvate to pyruvate (Figure [S4](#SM1){ref-type="supplementary-material"}). Then, mycoplasmas generate ATP via a proton-translocating ATP synthase by oxidizing organic acids (pyruvate and lactate) to acetate and CO~2~. Moreover, the pyruvate kinase present in the genome of *Mycoplasma suis* is proposed to be required for the conversion of all NDPs and dNDPs to NTPs and dNTPs, respectively (Pollack et al., [@B33]). Hence, this protein is very important for energy production in *Mycoplasma* species, and the SNP in the pyruvate kinase-encoding gene may lead to the attenuation of *M. bovis*.

The different molecular functions of transketolase (Mbov_0212) include metal ion binding and transferase activity, and it is a key enzyme in the non-oxidative branch of the pentose phosphate pathway that transfers a two-carbon glycolaldehyde unit from a ketose donor to aldose-acceptor sugars (Jores et al., [@B19]). Moreover, transketolase is an immunodominant membrane protein that may be used as a biomarker for the serological diagnosis of contagious agalactia caused by *M. mycoides* subsp. *capri* (Corona et al., [@B9]). Hence, this protein may be involved in the immunogenicity and virulence of *M. bovis*.

ABC transporter proteins have different functions, including ATP binding, ATPase activity, and catalyzing the transmembrane movement of substances, such as importing sugars, amino acids, peptides, metal ions, and phosphates, and effluxing toxins, drugs, and proteins (Higgins et al., [@B17]). The Mbov_0742 gene, which contained a SNP only in strain P180, encodes a glycerol ABC transporter protein. The Mbov_0581 gene, which had an indel only in strain P180, encodes a multiple sugar ABC transporter protein. Both genes are considered to encode virulence-related factors in the VFDB. In addition, the Mbov_0134 and Mbov_0018 genes encoding ABC proteins responsible for the uptake of simple sugar and spermidine/putrescine were found to have SNPs in all three attenuated strains.

NADH dehydrogenase (Mbov_0299) is considered to be a virulence-related factor. It generates energy by transferring electrons from NADH (oxidation) to quinine. NADH and NADPH are possibly essential for the growth of *M. suis* (Guimaraes et al., [@B13]). In *Mycobacterium tuberculosis*, a mutant lacking NuoG, a subunit of the type I NADH dehydrogenase complex, exhibited attenuated growth *in vivo* (Blomgran et al., [@B3]). Hence, this gene mutation might be significantly related to the further attenuation of *M. bovis* strain P180.

Phosphate acetyltransferase (PTA) (Mbov_0567) catalyzes the formation of acetyl phosphate and acetyl CoA, which are used in many metabolic pathways, e.g., in taurine and hypotaurine metabolism, pyruvate metabolism, propanoate metabolism, and methane metabolism (Figure [S5](#SM1){ref-type="supplementary-material"}). Acetyl-phosphate regulates various cellular processes, including cell division, outer membrane protein expression, osmoregulation, and biofilm development. Moreover, acetyl phosphate is required for the activation of the Rrp2-RpoN-RpoS pathway, which serves as a global signal in bacterial pathogenesis by activating virulent genes (Xu et al., [@B43]). Moreover, *Salmonella enterica* serovar Typhimurium (Kim et al., [@B24]) and *Vibrio cholerae* (Chiang and Mekalanos, [@B8]) PTA mutants were shown to exhibit impaired growth and attenuated virulence. In addition, because of a SNP in Mbov_0567, a proline residue was converted to threonine, resulting in polarity change that might be significant in virulence attenuation.

In addition, membrane proteins influence cell shape, cell division, motility, and adhesion to host cells, and they are thought to be integrally involved in the pathogenesis of mycoplasmas. As is known, adhesion and invasion are generally considered to be virulence-associated processes. *M. bovis* can adhere to and invade epithelial cells and immune cells. Membrane lipoproteins, such as Vsps, enolase, and Vpmax, play significant roles in the adhesion of *M. bovis* to host cells (Burki et al., [@B4]). Five genes encoding membrane proteins were shown to have SNPs, and four of them were predicted to encode secretory proteins with signal peptides, including Mbov_0393, Mbov_0525, Mbov_0579, and Mbov_0797. Among them, Mbov_0797 encodes a Vsp, and it was predicted to be a virulence-related factor, Mbov_0579 was predicted to encode the ADP-ribosyltransferase CDTa, which contains functional domains of the community-acquired respiratory distress syndrome toxin of *M. pneumoniae* (Kannan et al., [@B21]).

Alternation of H~2~O~2~ production in the attenuated strains
------------------------------------------------------------

H~2~O~2~ is thought to be a significant virulence related factor in *M. pneumoniae, M. mycoides*, and *Mycoplasma ovipneumoniae*. Secondary metabolites are considered to play significant roles in the pathogenesis of some *Mycoplasma* species (Pilo et al., [@B32]; Hames et al., [@B16]). For example, H~2~O~2~ was demonstrated to be a major virulence-related factor that leads to cell death and lipid peroxidation in *M. pneumoniae* (Hames et al., [@B16]) and *MmmSC* (Pilo et al., [@B32]). Moreover, activation of glycerol utilization and overproduction of H~2~O~2~ occurred during intracellular infection with *Mycoplasma gallisepticum* (Matyushkina et al., [@B28]). Although an *in vitro* H~2~O~2~ assay for *M. bovis* field strains showed that variations in H~2~O~2~ production did not correlate with *M. bovis* virulence (Schott et al., [@B37]), *in vitro* passaging an *M. bovis* strain resulted in decreased levels of H~2~O~2~ production (Khan et al., [@B23]).

To confirm that H~2~O~2~ production was affected by the mutations in the attenuated strains, H~2~O~2~ production was tested in the wild-type strain HB0801 (P1), strains of various passages (25, 50, 75, 100, 115, 150, and 180), and eight mutants specific to the genes in the 14.2-kb deleted region (Mbov_0723, Mbov_0724, Mbov_0725, Mbov_0727, Mbov_0730, Mbov_0732, Mbov_0734, and Mbov_0735). The results showed a decreasing tendency of H~2~O~2~ production following increasing numbers of passages in *M. bovis*. The differences in H~2~O~2~ production between passage 1 and the serially passaged strains began to be statistically significant from passage 115 and onward (*p* \< 0.01) (Figure [4A](#F4){ref-type="fig"}). Interestingly, other researchers measured the production of H~2~O~2~ by *in vitro* passaged strains including the 50th, 100th, and 200th passages of *M. bovis*, and they showed a similar decreasing tendency of H~2~O~2~ production with increasing numbers of passages (Khan et al., [@B23]). Random transposon mutagenesis was used recently to generate *M. bovis* mutants (Sharma et al., [@B38]). With the availability and further improvement of these techniques, it should be possible to obtain detailed information about the interactions of *M. bovis* with its host in the near future. To differentiate the effects resulting from the 14.2-kb deleted region and the SNPs in related genes on H~2~O~2~ production, transposon-disrupted mutants were further characterized. However, there was no significant difference in H~2~O~2~ production by the mutants compared with the P1 strain (Figure [4B](#F4){ref-type="fig"}). Therefore, these genes in the 14.2-kb deleted region might not affect H~2~O~2~ production, or a single gene could only contribute slightly to H~2~O~2~ production. In fact, other genes outside the 14.2-kb deleted region that have SNPs and indels might be associated with altered H~2~O~2~ production via the impairment of various pathways (Figure [5](#F5){ref-type="fig"}), such as ABC transporters (Figure [S6](#SM1){ref-type="supplementary-material"}), carbon metabolism (Figure [S7](#SM1){ref-type="supplementary-material"}), biosynthesis of amino acids (Figure [S8](#SM1){ref-type="supplementary-material"}), glycolysis/gluconeogenesis (Figure [S9](#SM1){ref-type="supplementary-material"}), and pyruvate metabolism (Figure [S10](#SM1){ref-type="supplementary-material"}).

![**Production of H~**2**~O~**2**~ by 10^**8**^ cells/ml determined after a 30-min incubation with 10 mM glycerol**. Significant differences between groups are highlighted with asterisks. **(A)** Comparison of the wild-type *M. bovis* HB0801 strain and strains that were subjected to different numbers of passages during *in vitro* growth. **(B)** Comparison of the wild-type *M. bovis* HB0801 with different transposon-disrupted mutants during *in vitro* growth. These transposon-disrupted mutants were produced using the virulent *M. bovis* HB0801 and a Tn4001 transposon. Gene numbers of *M. bovis* given are as follows. 0723 = Mbov_0723, 0724 = Mbov_0724, 0725 = Mbov_0725, 0727 = Mbov_0727, 0730 = Mbov_0730, 0732 = Mbov_0732, 0734 = Mbov_0734, and 0735 = Mbov_0735.](fcimb-07-00177-g0004){#F4}

![**Schematic illustration of H~**2**~O~**2**~ production in mycoplasmas affected by multiple pathways, including glycerol metabolism**. Glycerol is transported into the cell by the GlpF membrane transporter. Glycerol is phosphorylated to glycerol-3-P by GlpK (glycerol kinase). Moreover, glycerol-3-phosphate is also recycled through ABC transporters (UgpA, C, and E). Glycerol-3-phosphate is converted to dihydroxyacetone phosphate (DHAP) by oxidoreductase GlpO. H~2~O~2~ is secreted during and after the whole process. Mutations in the genes of mycoplasmas related to these metabolic pathways lead to decreased H~2~O~2~ production. CM, cell membrane. The ![](fcimb-07-00177-i0001.jpg) sign shows the mutations in the pathways, and mutated genes are listed with this sign.](fcimb-07-00177-g0005){#F5}

Conclusions {#s4}
===========

We first sequenced the genomes of three attenuated *M. bovis* strains, HB0801-P115, HB0801-P150, and HB0801-P180, with various levels of virulence, and we performed a comprehensive comparative genomics analysis of these strains. The results not only enrich the basic genomic data for further research of *M. bovis*, but they also provide guidance for exploring the molecular mechanisms of *M. bovis* virulence and pathogenesis.
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